# Spyre Therapeutics, Inc.: Form 8-K, filed Apr 13, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2026-04-13
- Accepted by EDGAR: Apr 13, 2026, 07:46 ET
- Period: 2026-04-13
- Accession: 0001628280-26-024831
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000162828026024831/syre-20260413.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000162828026024831/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000162828026024831/syre-20260413.htm

Filed Apr 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-024831. Last ingested by Listed: Nov 3, 2026, 18:46 ET. No prices; not investment advice.